Company Profile
Candel Therapeutics Stock Price, News & Analysis
- Ticker:
- CADL
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- United States
Stock performance
10.58 USD (+1.15%)
Close
Last updated: August 6, 2026
617M USD
Market cap
Why the stock is moving
As of Aug 6, 2026, CADL closed up 1.15% at $10.58. No new same-company headline was identified in the current news window.
Company overview
Business overview
Candel Therapeutics is an oncology company focused on virus-based immunotherapy and cancer treatment. Its platform aims to stimulate immune response against tumors in localized disease settings.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, Candel sits in specialty oncology biotechnology.
Business Model Characteristics
The company depends on clinical data, immunotherapy differentiation, and the ability to build a focused cancer franchise.
Position Within the Biotechnology Landscape
Candel is a catalyst-driven oncology name whose stock is sensitive to early clinical and platform updates.
Future catalysts
Near-term attention for Candel Therapeutics is likely to stay on CAN-2409 in aglatimagene besadenovec (aglatimagene or CAN-2409) in local.... The current setup is really about Company plans to submit a Biologics License Application (BLA) for aglatimagene besadenovec (aglatimagene or CAN-2409) in localized, intermediate- to high-risk prostate cancer in.... That is where the next meaningful signal is most likely to come from.
Recent news
- 01
Candel Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Source: Candel Therapeutics
- 02
Candel Therapeutics to Present Extended Data from Phase 3 Results of Aglatimagene Besadenovec at ASTRO 2026
Source: Candel Therapeutics
- 03
Candel Therapeutics to Present at Canaccord Genuity’s 46th Annual Growth Conference in Boston
Source: Candel Therapeutics
- 04
Candel Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Source: Candel Therapeutics
- 05
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Candel Therapeutics (CADL)?
Candel Therapeutics (CADL) most recently closed at 10.58 USD, a +1.15% move versus the previous session.
What is the market cap of Candel Therapeutics (CADL)?
Candel Therapeutics currently has a market capitalization of 617M USD on BioPharmSignal.
What does Candel Therapeutics do?
Candel Therapeutics is an oncology company focused on virus-based immunotherapy and cancer treatment. Its platform aims to stimulate immune response against tumors in localized disease settings.
On which exchange is CADL stock listed?
Candel Therapeutics (CADL) is associated with NASDAQ, United States, Biopharma.
What is CAN-2409?
Near-term attention for Candel Therapeutics is likely to stay on CAN-2409 in aglatimagene besadenovec (aglatimagene or CAN-2409) in local....
Which conditions is Candel Therapeutics targeting with CAN-2409?
Candel Therapeutics is associated with oncology, cancer therapeutics based on its company overview and current catalyst commentary.
How does Candel Therapeutics describe recent progress with CAN-2409?
Near-term attention for Candel Therapeutics is likely to stay on CAN-2409 in aglatimagene besadenovec (aglatimagene or CAN-2409) in local....
What is Candel?
Candel Therapeutics is an oncology company focused on virus-based immunotherapy and cancer treatment.